NCT02888210View on ClinicalTrials.gov

A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

September 3, 2016

Primary Completion Date

November 22, 2017

Study Completion Date

November 22, 2017

Conditions

Cataract

Interventions

DEVICE

MD-15 Intraocular Lens

Trial Locations (1)

Unknown

Tokyo

All Listed Sponsors

lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY

NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery | Biotech Hunter | Biotech Hunter